CD4 News and Research

RSS
SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

SARS-CoV-2 variants do not substantially affect CD4+ and CD8+ T cell responses, study shows

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Results from phase 2 trial of Novavax recombinant nanoparticle SARS-CoV-2 vaccine

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

Researchers examine long-term immune responses following COVID-19 across clinically diverse cohort

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

Protein kinase inhibitors could help treat immunodeficiency in HIV patients

Hyperactive immune system contributes to COVID-19 severity, lung damage

Hyperactive immune system contributes to COVID-19 severity, lung damage

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

Glycan switch may explain why SARS-CoV-2 causes such variable symptoms

An overview of spike protein antigen COVID-19 vaccine candidates

An overview of spike protein antigen COVID-19 vaccine candidates

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

Nanoparticle COVID-19 vaccine stimulates robust and long lasting immunity in primates

Scientists discover new immunotherapy target for malignant brain tumors

Scientists discover new immunotherapy target for malignant brain tumors

LMU researchers study T cell exhaustion

LMU researchers study T cell exhaustion

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

Both mRNA vaccines protect against emerging variants of SARS-CoV-2

HIV: New therapeutic approach to restore the effectiveness of immune cells

HIV: New therapeutic approach to restore the effectiveness of immune cells

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

SHREK proteins mediate broad spectrum antiviral host immunity, including against SARS-CoV-2

SARS-CoV-2 N501Y mutation adversely affects cellular immune response

SARS-CoV-2 N501Y mutation adversely affects cellular immune response

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

Novel biomarker may help identify which pancreatic cancer patients respond to CD40 agonists

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

POSTECH researchers discover mechanism behind intestinal epithelial lymphocyte differentiation

Experimental intranasal influenza vaccine produces durable immune response

Experimental intranasal influenza vaccine produces durable immune response

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Long COVID-19 symptoms not associated with reduced cell-mediated immunity, finds study

Researchers explore adaptive immunity against human coronaviruses

Researchers explore adaptive immunity against human coronaviruses